<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Drugs Acting on the Central Nervous System - Pharmacology and Pharmacotherapeutics</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="../styles/main.css">
    
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <!-- Floating Table of Contents -->
    <div class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span>
            <span>Contents</span>
        </div>
        <ul class="floating-toc-list">
            <!-- JS will populate this -->
        </ul>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>üß†</span>
                        <span>Section II</span>
                    </div>
                    <h1 class="document-title">Drugs Acting on the Central Nervous System</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Chapters 5-15</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>120 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- START: Chapter 5 -->
                    <section class="content-section" id="chapter-5">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">üåê</span>
                                General Considerations
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Anatomically, the nervous system in higher animals can be divided into:</p>
                            <ul>
                                <li>The central nervous system (CNS); and</li>
                                <li>The peripheral nervous system consisting of somatic and autonomic nerve fibres.</li>
                            </ul>
                            
                            <p>The CNS is not only concerned with the regulation of specialised functions like circulation, digestion and respiration but it also is responsible for the psychic processes such as feeling, attitude, thoughts and memory. The ability to think logically, to learn from past experiences and to communicate appropriately are the unique qualities of man and can be attributed to the development of the highly specialised CNS.</p>

                            <p>Both the CNS and peripheral nervous system are analogous to an elaborate system of telegraphy wherein numerous wires and connections in the form of neurons and synapses bring in information from both internal and external sources. This information is received, 'decoded', decisions are made by various centres in CNS and instructions are sent out to various peripheral tissues to produce appropriate responses such as:</p>
                            <ul>
                                <li>Psychic, as manifested by change in emotions, thought and attitude.</li>
                                <li>Somatic, as demonstrated by various types of body movements; and</li>
                                <li>Autonomic, as indicated by changes in respiration, circulation and visceral functions.</li>
                            </ul>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 5.1: Functions of various parts of central nervous system</caption>
                                    <thead>
                                        <tr>
                                            <th>Part of CNS</th>
                                            <th>Functions attributed</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Cerebral cortex</strong></td>
                                            <td>Higher functions like judgement, memory, fine voluntary movements, fine pain, tactile discrimination and temperature, special senses like vision, smell and hearing. It also acts as an important coordinator and exerts inhibitory control over lower centres.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Frontal lobes</strong></td>
                                            <td>Thinking, integration of emotional behaviour.</td>
                                            <td></td>
                                        </tr>
                                        <tr>
                                            <td><strong>Limbic system</strong></td>
                                            <td>Integrates emotional state with motor and visceral activities.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Basal ganglia</strong></td>
                                            <td>Extrapyramidal control of skeletal muscle tone, co-ordination of posture. Lesions produce tremors and rigidity in flexion.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Thalamus</strong></td>
                                            <td>Relay centre for sensory pathways to cortex. Conscious appreciation of pain, temperature and crude touch sensations. Exerts regulatory control over visceral functions.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Hypothalamus</strong></td>
                                            <td>Control of the autonomic nervous system, control of adenohypophysis. Important centre for integration of eating, drinking, sexual behaviour, temperature regulation, sleep, circadian rhythms and other vegetative functions.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Cerebellum</strong></td>
                                            <td>Control of vestibular function and body posture.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Reticular formation</strong></td>
                                            <td>Sleep-wakefulness cycle, control of blood pressure, respiration, swallowing, vomiting; transmission of crude pain, voluntary muscle tone and posture; control of upper motor neurons.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Spinal cord</strong></td>
                                            <td>Reflex movements, control of muscle tone (particularly the red muscles) and the upper and the lower motor neurons through presynaptic and post-synaptic inhibition.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <p><strong>Drugs act on the CNS:</strong></p>
                            <ul>
                                <li>Directly on neurons and modify the neuronal functions.</li>
                                <li>Reflexly by sending afferent impulses to the CNS via the chemoreceptors, baroreceptors and peripheral nerves, thereby eliciting psychic, somatic or visceral responses; and</li>
                                <li>By affecting the nutrition and oxygen supply of the CNS by altering its blood supply or affecting its metabolism e.g. by causing hypoglycemia or ammonia intoxication.</li>
                            </ul>
                            
                            <p>To reach the CNS, a drug must have a high lipid solubility (high oil/water partition coefficient) or a specialised transport mechanism. Ionized drugs normally cannot cross BBB.</p>

                            <p><strong>Neurochemical transmission in the nervous system:</strong> Because communication within the nervous system is almost exclusively through chemical messengers, neurosecretion is a fundamental property of all neurons. A neurosecretion is a chemical released at the nerve terminals; those released into the blood circulation are called neurohormones e.g. hypothalamic hormones released into the hypothalamo-pituitary portal circulation.</p>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 5.2: Some neurotransmitters found in the nervous system</caption>
                                    <thead>
                                        <tr>
                                            <th>Name</th>
                                            <th>Distribution</th>
                                            <th>Effects</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr><td colspan="3"><strong>- Amines</strong></td></tr>
                                        <tr>
                                            <td><strong>Acetylcholine (ACh)</strong></td>
                                            <td>Widely distributed in almost all regions in CNS, predominantly in cerebral cortex, ascending reticular system, cerebellum and spinal cord.</td>
                                            <td>Mainly excitatory and at some places inhibitory in nature. Central effects can be blocked by atropine.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Noradrenaline (NA)</strong></td>
                                            <td>High concentration in the hypothalamus, limbic system and reticular formation in the brain stem.</td>
                                            <td>Generally excitatory and inhibitory in few areas.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Dopamine (DA)</strong></td>
                                            <td>Mainly in the basal ganglia, to some extent in the median eminence of hypothalamus, adenohypophysis and frontal cortex.</td>
                                            <td>Predominantly inhibitory action and in some areas excitatory. Deficiency causes extrapyramidal disturbances.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>5-Hydroxytryptamine (5-HT, serotonin)</strong></td>
                                            <td>Extends into the cerebral cortex, raphe nucleus in pons and medulla, hippocampal areas.</td>
                                            <td>Both excitatory and inhibitory effects.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Histamine (H)</strong></td>
                                            <td>Distribution similar to NA and 5-HT but irregular.</td>
                                            <td>Mainly inhibitory effects. Functions uncertain.</td>
                                        </tr>
                                        <tr><td colspan="3"><strong>- Amino acids</strong></td></tr>
                                        <tr>
                                            <td><strong>L-glutamic acid and aspartic acid (EAA)</strong></td>
                                            <td>Widely distributed in CNS and spinal cord</td>
                                            <td>Excitatory effects.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Gamma-aminobutyric acid (GABA), glycine</strong></td>
                                            <td>GABA in CNS; glycine mainly in the spinal cord and brain stem.</td>
                                            <td>Inhibitory effects in brain and spinal cord.</td>
                                        </tr>
                                        <tr><td colspan="3"><strong>- Peptides</strong></td></tr>
                                        <tr>
                                            <td><strong>Substance P</strong></td>
                                            <td>Hypothalamus, thalamus, basal ganglia; the dorsal column and dorsal roots of the spinal cord; enteric nervous system (ENS)</td>
                                            <td>Excitatory</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Cholecystokinin</strong></td>
                                            <td>Brain (cortex, hippocampus, limbic system and hypothalamus), pancreas</td>
                                            <td>Inhibits eating and stimulates oxytocin release.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251214-1b57f618.jpeg" 
                                         alt="Sagittal section of the brain showing Dopaminergic pathways" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 5.1: Sagittal section of the brain showing Dopaminergic pathways. VTA: Ventral Tegmental Area; SN: Substantia Nigra; HT: Hypothalamus; P: Pituitary; NA: Nucleus Accumbens.</figcaption>
                            </figure>
                        </div>
                    </section>
                    <!-- END: Chapter 5 -->

                    <!-- START: Chapter 6 -->
                    <section class="content-section" id="chapter-6">
                        <div class="section-header">
                            <div class="section-number">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">üç∑</span>
                                Aliphatic Alcohols
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Ethyl Alcohol (Ethanol)</h3>
                            <p><strong>Pharmacological actions:</strong></p>
                            <ul>
                                <li><strong>Topical:</strong> Applied to the skin, it evaporates quickly. It has a cooling and refreshing effect, and is used for reducing the temperature in fevers. Higher concentrations denature proteins. Alcohol in the concentration of 70% by weight acts as an antiseptic.</li>
                                <li><strong>Gastrointestinal tract:</strong> Taken orally, it gives a local feeling of warmth and increases the salivary secretion. 50 ml of 7-10% alcohol increases the gastric secretion. Higher concentrations inhibit both gastric motility and secretion, and have a direct toxic effect on gastric mucosa.</li>
                                <li><strong>Central nervous system:</strong> Ethanol is primarily a CNS depressant and acts by enhancing the inhibitory $\mathrm{GABA}_{\mathrm{A}}$ receptor activity and inhibiting the excitatory NMDA receptors. The initial CNS effect is due to depression of the reticular activating system. The cortex is thus released from the integrating control or inhibitions required for purposeful activity.</li>
                                <li><strong>Cardiovascular system:</strong> Alcohol in moderate amounts dilates skin vessels by depressing the vasomotor centre, resulting in flushing and feeling of warmth. Regular consumption of alcohol is often associated with hypertension.</li>
                                <li><strong>Liver:</strong> Ethanol causes dose-related hepatotoxicity. The common effects are fatty infiltration and hepatomegaly.</li>
                            </ul>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251214-8c62fcb9.jpeg" 
                                         alt="Metabolism of alcohol" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 6.1: Metabolism of alcohol. 1: Inhibition by fomepizole; 2: Inhibition by disulfiram.</figcaption>
                            </figure>

                            <h3>Acute Alcohol Intoxication</h3>
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 6.1: Correlation of blood alcohol levels with behavioural changes</caption>
                                    <thead>
                                        <tr>
                                            <th>Blood concentration (mg per 100 ml)</th>
                                            <th>Behavioural changes</th>
                                            <th>Interpretation</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td>&lt;50</td>
                                            <td>Not significant</td>
                                            <td>Not under the influence of alcohol but may affect the reaction time</td>
                                        </tr>
                                        <tr>
                                            <td>50-100</td>
                                            <td>Feeling of exaltation, talkativeness</td>
                                            <td>Possibly under the influence</td>
                                        </tr>
                                        <tr>
                                            <td>100-200</td>
                                            <td>Emotionally unstable, motor incoordination, nystagmus</td>
                                            <td>Probably under the influence</td>
                                        </tr>
                                        <tr>
                                            <td>200-300</td>
                                            <td>Staggering, loss of self control</td>
                                            <td>Definitely under the influence</td>
                                        </tr>
                                        <tr>
                                            <td>300-400</td>
                                            <td>Stupor-dead drunk</td>
                                            <td>Grossly intoxicated</td>
                                        </tr>
                                        <tr>
                                            <td>400-500</td>
                                            <td>Coma, anaesthetic effect</td>
                                            <td></td>
                                        </tr>
                                        <tr>
                                            <td>&gt;500</td>
                                            <td>Respiratory arrest and death</td>
                                            <td></td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Chronic Alcoholism and Dependence</h3>
                            <p><strong>Withdrawal syndrome:</strong> Sudden withdrawal of alcohol in alcoholics leads to withdrawal syndrome. Delirium tremens, though rare, is the most severe component of the abstinence syndrome.</p>
                            
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 6.2: Alcohol withdrawal syndrome</caption>
                                    <tbody>
                                        <tr>
                                            <td><strong>Minor Symptoms</strong><br>(6-12 hours)</td>
                                            <td>Tremors, nausea, vomiting, sweating, tachycardia, hypertension, insomnia, anxiety and agitation.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Hallucinations</strong><br>(12-24 hours)</td>
                                            <td>Visual, auditory or tactile hallucinations with intact orientation.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Seizures</strong><br>(24-48 hours)</td>
                                            <td>Generalised tonic-clonic seizures.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Delirium Tremens</strong><br>(48-96 hours)</td>
                                            <td>Agitation, global confusion, disorientation, hallucinations, fever, autonomic hyperactivity.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <p><strong>Treatment of Alcohol Dependence:</strong></p>
                            <ul>
                                <li><strong>Detoxification:</strong> Benzodiazepines (diazepam, chlordiazepoxide) are the treatment of choice.</li>
                                <li><strong>Support therapy (Anti-craving drugs):</strong>
                                    <ul>
                                        <li><strong>Naltrexone:</strong> 50-100 mg once daily, reduces craving.</li>
                                        <li><strong>Acamprosate:</strong> Analogue of GABA, reduces voluntary alcohol consumption.</li>
                                        <li><strong>Disulfiram:</strong> Inhibits aldehyde dehydrogenase. Causes toxic reaction (antabuse reaction) if alcohol is consumed.</li>
                                    </ul>
                                </li>
                            </ul>

                            <h3>Methyl Alcohol (Methanol)</h3>
                            <p>This is used as a solvent. It is mainly oxidised to formaldehyde and subsequently to formic acid, which is toxic. Ingestion leads to CNS depression, acidosis, and toxic effects on retinal cells (blindness).</p>
                            
                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Treatment of Methanol Poisoning</h4>
                                </div>
                                <div class="callout-content">
                                    <ul>
                                        <li><strong>Ethyl alcohol:</strong> 10% IV; competes for alcohol dehydrogenase.</li>
                                        <li><strong>Fomepizole:</strong> 100 mg IV; inhibits alcohol dehydrogenase.</li>
                                        <li><strong>Folinic acid/Folic acid:</strong> To promote metabolic degradation of formate.</li>
                                        <li><strong>Sodium bicarbonate:</strong> To correct acidosis.</li>
                                        <li><strong>Hemodialysis:</strong> In severe cases.</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: Chapter 6 -->

                    <!-- START: Chapter 7 -->
                    <section class="content-section" id="chapter-7">
                        <div class="section-header">
                            <div class="section-number">07</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíâ</span>
                                General Anaesthetics
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>General anaesthetics are the agents which bring about loss of all modalities of sensation, particularly pain (analgesia), inhibition of autonomic reflexes, relaxation of skeletal muscle, amnesia and a reversible loss of consciousness.</p>

                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>Inhalational Anaesthetics</h4>
                                    <ul>
                                        <li><strong>Volatile liquids:</strong> Diethyl ether, Halothane, Enflurane, Isoflurane, Desflurane, Sevoflurane.</li>
                                        <li><strong>Gases:</strong> Nitrous oxide.</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Intravenous Anaesthetics</h4>
                                    <ul>
                                        <li><strong>Ultra short acting barbiturates:</strong> Thiopental sodium, Methohexital.</li>
                                        <li><strong>Propofol</strong></li>
                                        <li><strong>Benzodiazepines:</strong> Midazolam, Diazepam.</li>
                                        <li><strong>Dissociative:</strong> Ketamine.</li>
                                        <li><strong>Opioids:</strong> Fentanyl.</li>
                                        <li><strong>Miscellaneous:</strong> Etomidate, Dexmedetomidine.</li>
                                    </ul>
                                </div>
                            </div>

                            <h3>Stages of Anaesthesia (Guedel)</h3>
                            <p>Refers mainly to ether.</p>
                            <ul>
                                <li><strong>Stage I: Stage of Analgesia:</strong> From beginning of inhalation to loss of consciousness. Analgesia is produced.</li>
                                <li><strong>Stage II: Stage of Delirium:</strong> From loss of consciousness to beginning of surgical anaesthesia. Excitement, shouting, increased muscular activity, irregular respiration.</li>
                                <li><strong>Stage III: Stage of Surgical Anaesthesia:</strong> Regular respiration, loss of reflexes, muscle relaxation. Divided into 4 planes.</li>
                                <li><strong>Stage IV: Stage of Respiratory Paralysis:</strong> Severe depression of medullary centres, respiratory arrest.</li>
                            </ul>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251214-21123cd4.jpeg" 
                                         alt="Structure of Ether and Halothane" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig 7.2: Chemical structures of Ether and Halothane.</figcaption>
                            </figure>

                            <h3>Important Agents</h3>
                            <p><strong>Halothane:</strong> Non-inflammable, pleasant, potent. Causes bronchodilatation. <strong>Disadvantages:</strong> Poor analgesic, muscle relaxation inadequate, sensitises heart to catecholamines (arrhythmias), hepatotoxicity (rare).</p>
                            <p><strong>Isoflurane:</strong> Muscle relaxant, bronchodilator, does not sensitise heart to catecholamines. Preferred agent in neurosurgery.</p>
                            <p><strong>Nitrous Oxide:</strong> "Laughing gas". Good analgesic, poor anaesthetic (MAC 105%). Used with O2 and other agents. <strong>Disadvantages:</strong> Diffusion hypoxia, expansion of closed gas spaces (pneumothorax, etc.).</p>
                            <p><strong>Thiopental:</strong> Ultra short acting barbiturate. Rapid pleasant induction. Action terminated by redistribution to fat. Poor analgesic/muscle relaxant.</p>
                            <p><strong>Propofol:</strong> Rapid induction and recovery ("clear headed"). Anti-emetic. Used for day-care surgery. Pain on injection.</p>
                            <p><strong>Ketamine:</strong> Produces "Dissociative Anaesthesia" (analgesia, amnesia, catatonia). Raises BP and heart rate. Bronchodilator. Causes hallucinations/delirium during recovery.</p>

                            <p><strong>Neuroleptanalgesia:</strong> Combination of a neuroleptic (Droperidol) and an opioid (Fentanyl). Produces a state of apathy and analgesia where patient is conscious but indifferent.</p>
                        </div>
                    </section>
                    <!-- END: Chapter 7 -->

                    <!-- START: Chapter 8 -->
                    <section class="content-section" id="chapter-8">
                        <div class="section-header">
                            <div class="section-number">08</div>
                            <h2 class="section-title">
                                <span class="title-icon">üí§</span>
                                Sedatives, Hypnotics and Sleep Disorders
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>A <strong>hypnotic</strong> drug is one which produces sleep resembling natural sleep. A <strong>sedative</strong> is a drug that reduces excitement, calms the patient, and is commonly used as an anxiolytic.</p>

                            <h3>Benzodiazepines (BDZ)</h3>
                            <p><strong>Mechanism:</strong> Bind to specific BDZ binding site on $\mathrm{GABA}_{\mathrm{A}}$ receptor complex. They facilitate GABA action by increasing the <em>frequency</em> of chloride channel opening. (Barbiturates increase the <em>duration</em>).</p>
                            
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251214-2d5810e8.jpeg" 
                                         alt="GABA-A Receptor Complex" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 8.3: The GABA<sub>A</sub> receptor complex showing binding sites.</figcaption>
                            </figure>

                            <p><strong>Actions:</strong> Anxiolytic, Sedative-Hypnotic, Anticonvulsant, Muscle relaxant, Anterograde amnesia.</p>
                            <p><strong>Antagonist:</strong> <strong>Flumazenil</strong> is a specific competitive antagonist used in BDZ poisoning.</p>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 8.1: Benzodiazepine derivatives and oral doses</caption>
                                    <thead>
                                        <tr>
                                            <th>Name</th>
                                            <th>Hypnotic Dose (mg)</th>
                                            <th>Daily Anxiolytic Dose (mg)</th>
                                            <th>Half-life Category</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Diazepam</strong></td>
                                            <td>5-10</td>
                                            <td>10-30</td>
                                            <td>Long (>24 hrs)</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Flurazepam</strong></td>
                                            <td>15-30</td>
                                            <td>15-30</td>
                                            <td>Long</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Nitrazepam</strong></td>
                                            <td>5-10</td>
                                            <td>5-10</td>
                                            <td>Intermediate (5-24 hrs)</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Lorazepam</strong></td>
                                            <td>0.5-2</td>
                                            <td>2-4</td>
                                            <td>Intermediate</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Temazepam</strong></td>
                                            <td>7.5-30</td>
                                            <td>10-30</td>
                                            <td>Intermediate</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Midazolam</strong></td>
                                            <td>7.5-15</td>
                                            <td>-</td>
                                            <td>Short (<5 hrs)</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Triazolam</strong></td>
                                            <td>0.125-0.25</td>
                                            <td>-</td>
                                            <td>Short</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Non-benzodiazepine Hypnotics (Z-drugs)</h3>
                            <p><strong>Zolpidem, Zaleplon, Zopiclone:</strong> Bind selectively to the BDZ site on GABA receptors (specifically $\alpha1$ subunit). Potent hypnotics with minimal muscle relaxant or anticonvulsant effects. Less disruption of sleep architecture.</p>

                            <h3>Barbiturates</h3>
                            <p>Depress CNS in dose-dependent manner (Sedation -> Hypnosis -> Anaesthesia -> Coma). Induce liver enzymes. Low therapeutic index. Have largely been replaced by BDZ for insomnia.</p>
                            <p><strong>Specific uses:</strong> Phenobarbitone (Epilepsy), Thiopental (Anaesthesia).</p>
                        </div>
                    </section>
                    <!-- END: Chapter 8 -->

                    <!-- START: Chapter 9 -->
                    <section class="content-section" id="chapter-9">
                        <div class="section-header">
                            <div class="section-number">09</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ö°</span>
                                Drugs Effective in Seizure Disorders
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Classification of Seizures (Table 9.1)</h3>
                            <ul>
                                <li><strong>I Generalised seizures:</strong> Absence (Petit mal), Tonic-clonic (Grand mal), Tonic, Atonic, Myoclonic, Infantile spasms.</li>
                                <li><strong>II Focal seizures:</strong> Without cognitive impairment (Simple partial), With dyscognitive features (Complex partial), Focal leading to generalised.</li>
                            </ul>

                            <h3>Mechanisms of Antiepileptic Drugs (AEDs)</h3>
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 9.2: Mechanism of Action of AEDs</caption>
                                    <thead>
                                        <tr>
                                            <th>Mechanism</th>
                                            <th>Drugs</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Inhibition of Na<sup>+</sup> channels</strong></td>
                                            <td>Phenytoin, Carbamazepine, Lamotrigine, Topiramate, Zonisamide, Valproate</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Inhibition of T-type Ca<sup>++</sup> channels</strong></td>
                                            <td>Ethosuximide, Valproate, Zonisamide</td>
                                        </tr>
                                        <tr>
                                            <td><strong>GABA facilitation</strong></td>
                                            <td>Barbiturates, Benzodiazepines, Gabapentin (release), Vigabatrin (transaminase inhibition), Tiagabine (uptake inhibition), Valproate, Topiramate</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Glutamate inhibition</strong></td>
                                            <td>Lamotrigine, Topiramate, Felbamate</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Specific Drugs</h3>
                            <p><strong>Phenytoin:</strong> Blocks voltage-gated Na<sup>+</sup> channels. Kinetics: Saturation (zero order) kinetics at therapeutic levels. Induces liver enzymes. <strong>ADR:</strong> Gingival hyperplasia, hirsutism, megaloblastic anemia, osteomalacia, teratogenicity (fetal hydantoin syndrome), ataxia, nystagmus.</p>

                            <p><strong>Carbamazepine:</strong> Blocks Na<sup>+</sup> channels. Potent enzyme inducer. Used for partial and tonic-clonic seizures, and <strong>Trigeminal Neuralgia</strong>. <strong>ADR:</strong> Drowsiness, ataxia, hyponatremia.</p>

                            <p><strong>Sodium Valproate:</strong> Broad spectrum. Blocks Na<sup>+</sup> channels, T-type Ca<sup>++</sup> channels, and increases GABA. Enzyme inhibitor. Used for absence, myoclonic, and tonic-clonic seizures. <strong>ADR:</strong> Hepatotoxicity (rare but serious), weight gain, hair loss, teratogenicity (spina bifida).</p>

                            <p><strong>Ethosuximide:</strong> Blocks T-type Ca<sup>++</sup> channels in thalamus. Specific for Absence Seizures.</p>

                            <p><strong>Newer AEDs:</strong> Lamotrigine, Gabapentin, Topiramate, Levetiracetam, Tiagabine, Vigabatrin. Generally better tolerated, fewer interactions.</p>

                            <h3>Management of Status Epilepticus</h3>
                            <p>A medical emergency. Convulsive seizure lasting >15-30 mins.</p>
                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">üöë</span>
                                    <h4 class="callout-title">Treatment Protocol (Table 9.9)</h4>
                                </div>
                                <div class="callout-content">
                                    <ol>
                                        <li>Maintain airway, breathing, circulation.</li>
                                        <li><strong>Lorazepam</strong> 4 mg IV slowly (drug of choice) OR Diazepam 10 mg IV.</li>
                                        <li>Follow with <strong>Phenytoin</strong> 15-20 mg/kg IV infusion (in saline, not glucose) to prevent recurrence.</li>
                                        <li>If resistant: Phenobarbitone, Valproate IV, or General Anaesthesia (Propofol/Thiopental).</li>
                                    </ol>
                                </div>
                            </div>
                            
                            <!-- MORE CONTENT TO FOLLOW - PLEASE PROMPT 'CONTINUE' -->
                        </div>
                    </section>
                    <!-- END: Chapter 9 -->
  <!-- START: Chapter 10 -->
                    <section class="content-section" id="chapter-10">
                        <div class="section-header">
                            <div class="section-number">10</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Opioid Analgesics and Antagonists
                            </h2>
                        </div>

                        <div class="content-card">
                            <p><strong>Pain</strong> is an unpleasant sensory and emotional experience, associated with actual or potential tissue damage. <strong>Analgesics</strong> are drugs which relieve pain without causing loss of consciousness.</p>

                            <h3>Classification</h3>
                            <ul>
                                <li><strong>Agonists:</strong> Morphine, Codeine, Pethidine, Methadone, Fentanyl, Tramadol.</li>
                                <li><strong>Partial Agonists:</strong> Buprenorphine.</li>
                                <li><strong>Mixed Agonist-Antagonists:</strong> Pentazocine, Nalbuphine, Butorphanol.</li>
                                <li><strong>Antagonists:</strong> Naloxone, Naltrexone.</li>
                            </ul>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251214-07879502.jpeg" 
                                         alt="Classification of Opium Alkaloids" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 10.1: Chemical classification of Opium Alkaloids.</figcaption>
                            </figure>

                            <h3>Mechanism of Action</h3>
                            <p>Opioids act on specific G-protein coupled receptors: <strong>Mu ($\mu$), Kappa ($\kappa$), and Delta ($\delta$)</strong>. They inhibit adenylate cyclase, facilitate $\mathrm{K}^+$ channel opening (hyperpolarisation), and inhibit $\mathrm{Ca}^{++}$ channel opening (preventing transmitter release).</p>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 10.1: Pharmacological effects associated with opioid receptor types</caption>
                                    <thead>
                                        <tr>
                                            <th>Receptor</th>
                                            <th>Effects</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Mu ($\mu$)</strong></td>
                                            <td>Supraspinal/spinal analgesia, euphoria, respiratory depression, sedation, miosis, decreased GI motility, physical dependence.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Kappa ($\kappa$)</strong></td>
                                            <td>Spinal analgesia, sedation, miosis, dysphoria, psychomimetic effects.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Delta ($\delta$)</strong></td>
                                            <td>Spinal analgesia, decreased GI motility.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Morphine</h3>
                            <p><strong>Pharmacological Actions:</strong></p>
                            <ul>
                                <li><strong>CNS:</strong> Analgesia, Euphoria (or Dysphoria), Sedation, Respiratory depression (dose-dependent), Cough suppression, Miosis (pin-point pupils), Nausea/Vomiting (CTZ stimulation).</li>
                                <li><strong>CVS:</strong> Vasodilatation (histamine release), hypotension (postural). Used in LVF (relieves dyspnoea/anxiety, reduces preload).</li>
                                <li><strong>GI Tract:</strong> Increases tone (spasm), decreases motility $\rightarrow$ Constipation. Increases biliary pressure.</li>
                                <li><strong>GU Tract:</strong> Urinary retention.</li>
                            </ul>

                            <p><strong>Acute Morphine Poisoning:</strong> Triad of Respiratory depression, Pin-point pupils, and Coma. Treatment: Respiratory support and <strong>Naloxone</strong> (specific antagonist).</p>

                            <h3>Pethidine (Meperidine)</h3>
                            <p>Synthetic opioid. <strong>Differences from Morphine:</strong></p>
                            <ul>
                                <li>Less spasmogenic (less constipation/biliary spasm).</li>
                                <li>Has atropine-like action (tachycardia, dry mouth).</li>
                                <li>No antitussive activity.</li>
                                <li>Toxic metabolite (Norpethidine) causes excitation/convulsions.</li>
                                <li>Interacts with MAO inhibitors (excitation/coma).</li>
                            </ul>

                            <h3>Other Opioids</h3>
                            <p><strong>Methadone:</strong> Long acting, effective orally. Used for maintenance in opioid dependence (substitution therapy).</p>
                            <p><strong>Tramadol:</strong> Weak $\mu$ agonist + inhibits NA/5-HT reuptake. Less respiratory depression/addiction.</p>
                            <p><strong>Fentanyl:</strong> 100x more potent than morphine. Rapid onset, short duration. Used in anaesthesia and transdermal patches.</p>
                            <p><strong>Buprenorphine:</strong> Partial $\mu$ agonist. Long duration, tight binding. Precipitates withdrawal in addicts.</p>
                            <p><strong>Pentazocine:</strong> Mixed agonist/antagonist ($\kappa$ agonist, weak $\mu$ antagonist). Causes dysphoria/psychomimetic effects.</p>
                        </div>
                    </section>
                    <!-- END: Chapter 10 -->

                    <!-- START: Chapter 11 -->
                    <section class="content-section" id="chapter-11">
                        <div class="section-header">
                            <div class="section-number">11</div>
                            <h2 class="section-title">
                                <span class="title-icon">üî•</span>
                                NSAIDs and Antipyretic Analgesics
                            </h2>
                        </div>

                        <div class="content-card">
                            <p><strong>Non-steroidal anti-inflammatory drugs (NSAIDs)</strong> relieve pain, reduce fever, and suppress inflammation by inhibiting the enzyme <strong>Cyclooxygenase (COX)</strong>, thereby blocking prostaglandin (PG) synthesis.</p>

                            <div class="callout callout--info">
                                <div class="callout-header">
                                    <span class="callout-icon">üîÑ</span>
                                    <h4 class="callout-title">Mechanism of Action</h4>
                                </div>
                                <div class="callout-content">
                                    <ul>
                                        <li><strong>COX-1:</strong> Constitutive. physiologic (gastric protection, platelet aggregation, renal function).</li>
                                        <li><strong>COX-2:</strong> Inducible (at sites of inflammation).</li>
                                    </ul>
                                    <p>Traditional NSAIDs inhibit both. Selective COX-2 inhibitors spare COX-1 (less GI toxicity) but may increase cardiovascular risk.</p>
                                </div>
                            </div>

                            <h3>Salicylates (Aspirin)</h3>
                            <p><strong>Actions:</strong> Analgesic, Antipyretic, Anti-inflammatory. Irreversibly inhibits platelet COX (Antiplatelet action for 7-10 days).</p>
                            <p><strong>Adverse Effects:</strong> Gastric irritation/ulceration, Bleeding tendency, Hypersensitivity (bronchospasm), Salicylism (tinnitus, vertigo), Reye's syndrome (avoid in viral fever in children).</p>
                            <p><strong>Uses:</strong> Pain, Fever, RA, OA, Rheumatic fever, Prophylaxis of MI/Stroke (antiplatelet).</p>

                            <h3>Para-aminophenol Derivatives (Paracetamol)</h3>
                            <p>Potent analgesic and antipyretic. <strong>Weak/No anti-inflammatory action.</strong> Does not cause gastric irritation or bleeding.</p>
                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Paracetamol Toxicity</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Toxic metabolite (NAPQI) causes hepatic necrosis. Antidote: <strong>N-acetylcysteine</strong> (replenishes glutathione).</p>
                                </div>
                            </div>

                            <h3>Other NSAIDs</h3>
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Drug</th>
                                            <th>Key Characteristics</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Ibuprofen</strong></td>
                                            <td>Propionic acid derivative. Better tolerated than aspirin. Used for pain/inflammation.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Naproxen</strong></td>
                                            <td>Longer acting propionic acid derivative. Potent anti-inflammatory.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Diclofenac</strong></td>
                                            <td>Potent. Accumulates in synovial fluid. High GI/renal risk.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Indomethacin</strong></td>
                                            <td>Very potent anti-inflammatory. High toxicity (CNS, GI). Used in acute gout, PDA closure.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Piroxicam</strong></td>
                                            <td>Long acting (once daily). High GI toxicity.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Ketorolac</strong></td>
                                            <td>Potent analgesic (comparable to morphine). Used for post-op pain.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Selective COX-2 Inhibitors</h3>
                            <p><strong>Celecoxib, Etoricoxib:</strong> "Stomach friendly". Do not inhibit platelet aggregation. Increase risk of thrombotic events (MI, stroke). Contraindicated in IHD.</p>
                        </div>
                    </section>
                    <!-- END: Chapter 11 -->

                    <!-- START: Chapter 12 -->
                    <section class="content-section" id="chapter-12">
                        <div class="section-header">
                            <div class="section-number">12</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚òï</span>
                                CNS Stimulants
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Xanthine Alkaloids (Caffeine, Theophylline)</h3>
                            <p><strong>Mechanism:</strong> Phosphodiesterase inhibition (increase cAMP), Adenosine receptor blockade.</p>
                            <p><strong>Actions:</strong></p>
                            <ul>
                                <li><strong>CNS:</strong> Stimulation, alertness, reduced fatigue. High doses cause insomnia, tremors, convulsions.</li>
                                <li><strong>CVS:</strong> Heart stimulation (tachycardia), peripheral vasodilation (but cerebral vasoconstriction).</li>
                                <li><strong>Kidney:</strong> Weak diuresis.</li>
                                <li><strong>Smooth Muscle:</strong> Bronchodilation (Theophylline).</li>
                            </ul>

                            <h3>Psychomotor Stimulants</h3>
                            <p><strong>Amphetamines, Methylphenidate:</strong> Release NA/DA and block reuptake.</p>
                            <p><strong>Uses:</strong></p>
                            <ul>
                                <li><strong>ADHD:</strong> Methylphenidate, Atomoxetine.</li>
                                <li><strong>Narcolepsy:</strong> Amphetamine, Modafinil.</li>
                                <li><strong>Obesity:</strong> Anorexiants (Fenfluramine - withdrawn).</li>
                            </ul>
                            <p><strong>Adverse Effects:</strong> Addiction, psychosis, hypertension, growth retardation in children.</p>
                        </div>
                    </section>
                    <!-- END: Chapter 12 -->

                    <!-- START: Chapter 13 -->
                    <section class="content-section" id="chapter-13">
                        <div class="section-header">
                            <div class="section-number">13</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß†</span>
                                Antipsychotic Drugs
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Used for Schizophrenia and other psychoses. Also called Neuroleptics.</p>

                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>Typical (First Generation)</h4>
                                    <p>Block $\mathrm{D}_2$ receptors strongly. Treat positive symptoms. High risk of EPR.</p>
                                    <ul>
                                        <li><strong>Chlorpromazine:</strong> Low potency, high sedation/autonomic effects.</li>
                                        <li><strong>Haloperidol:</strong> High potency, less sedation, high EPR.</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Atypical (Second Generation)</h4>
                                    <p>Block $5\text{-HT}_{2A} > \mathrm{D}_2$. Treat positive and negative symptoms. Low EPR risk. Metabolic side effects.</p>
                                    <ul>
                                        <li><strong>Clozapine:</strong> Gold standard for resistant cases. Risk of Agranulocytosis.</li>
                                        <li><strong>Risperidone:</strong> High EPS at high doses. Hyperprolactinemia.</li>
                                        <li><strong>Olanzapine:</strong> Weight gain, diabetes risk.</li>
                                        <li><strong>Quetiapine:</strong> Sedating.</li>
                                        <li><strong>Aripiprazole:</strong> Partial D2 agonist.</li>
                                    </ul>
                                </div>
                            </div>

                            <h3>Adverse Reactions</h3>
                            <ul>
                                <li><strong>Extrapyramidal Reactions (EPR):</strong> Acute dystonia, Parkinsonism, Akathisia (restlessness), Tardive Dyskinesia (late, orofacial movements).</li>
                                <li><strong>Neuroleptic Malignant Syndrome (NMS):</strong> Rigidity, hyperthermia, autonomic instability. Medical emergency.</li>
                                <li><strong>Endocrine:</strong> Hyperprolactinemia (galactorrhea, amenorrhea, gynecomastia).</li>
                                <li><strong>Autonomic:</strong> Dry mouth, constipation, urinary retention, postural hypotension.</li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: Chapter 13 -->

                    <!-- START: Chapter 14 -->
                    <section class="content-section" id="chapter-14">
                        <div class="section-header">
                            <div class="section-number">14</div>
                            <h2 class="section-title">
                                <span class="title-icon">üòå</span>
                                Anxiolytics and Antidepressants
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Antidepressants</h3>
                            <p>Increase monoamines (NA, 5-HT) in synapse. Effect takes 2-4 weeks.</p>
                            
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Class</th>
                                            <th>Examples</th>
                                            <th>Features</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>TCAs</strong> (Tricyclic)</td>
                                            <td>Imipramine, Amitriptyline</td>
                                            <td>Block NA/5-HT reuptake. Also block M, $\alpha$, H1 receptors (Side effects: dry mouth, sedation, hypotension, cardiotoxicity).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>SSRIs</strong></td>
                                            <td>Fluoxetine, Sertraline, Escitalopram</td>
                                            <td>Selectively block 5-HT reuptake. Safer. Side effects: Nausea, sexual dysfunction. First line for Depression, OCD, Panic.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>SNRIs</strong></td>
                                            <td>Venlafaxine, Duloxetine</td>
                                            <td>Block NA/5-HT reuptake. Used in severe depression, neuropathic pain.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>MAO Inhibitors</strong></td>
                                            <td>Moclobemide (RIMA)</td>
                                            <td>Reversible inhibition of MAO-A. Safer than older irreversible MAOIs (Cheese reaction).</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Mood Stabilizers</h3>
                            <p><strong>Lithium Carbonate:</strong> Treatment of choice for Mania and Bipolar Disorder (Prophylaxis). Narrow therapeutic index (0.5-1.5 mEq/L). Toxicity: Tremor, ataxia, convulsions, renal toxicity, hypothyroidism.</p>
                            <p><strong>Alternatives:</strong> Valproate, Carbamazepine, Lamotrigine.</p>

                            <h3>Anxiolytics</h3>
                            <p><strong>Benzodiazepines:</strong> (See Chapter 8). Acute anxiety.</p>
                            <p><strong>Buspirone:</strong> Partial 5-HT<sub>1A</sub> agonist. Non-sedating, no dependence. Slow onset (weeks). For GAD.</p>
                            <p><strong>Beta-blockers (Propranolol):</strong> For performance anxiety (somatic symptoms).</p>
                        </div>
                    </section>
                    <!-- END: Chapter 14 -->

                    <!-- START: Chapter 15 -->
                    <section class="content-section" id="chapter-15">
                        <div class="section-header">
                            <div class="section-number">15</div>
                            <h2 class="section-title">
                                <span class="title-icon">üö∂</span>
                                Parkinsonism and Neurodegenerative Disorders
                            </h2>
                        </div>

                        <div class="content-card">
                            <p><strong>Parkinsonism:</strong> Degeneration of nigrostriatal dopaminergic neurons $\rightarrow$ Dopamine deficiency + Cholinergic preponderance. Features: Tremor, Rigidity, Bradykinesia.</p>

                            <h3>Drug Classification</h3>
                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>Dopaminergic System</h4>
                                    <ul>
                                        <li><strong>Precursor:</strong> Levodopa (+ Carbidopa)</li>
                                        <li><strong>DA Agonists:</strong> Bromocriptine, Ropinirole, Pramipexole</li>
                                        <li><strong>MAO-B Inhibitor:</strong> Selegiline, Rasagiline</li>
                                        <li><strong>COMT Inhibitor:</strong> Entacapone, Tolcapone</li>
                                        <li><strong>DA Releaser:</strong> Amantadine</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Cholinergic System</h4>
                                    <ul>
                                        <li><strong>Central Anticholinergics:</strong> Trihexyphenidyl (Benzhexol), Benztropine. Used mainly for tremor and drug-induced parkinsonism.</li>
                                    </ul>
                                </div>
                            </div>

                            <p><strong>Levodopa + Carbidopa:</strong> Gold standard. L-dopa crosses BBB and converts to DA. Carbidopa inhibits peripheral DOPA decarboxylase (does not cross BBB), reducing peripheral side effects and increasing brain entry. <strong>ADR:</strong> Nausea, hypotension, arrhythmias, dyskinesias, "On-off" phenomenon.</p>
                            
                            <h3>Alzheimer's Disease</h3>
                            <p>Cholinergic deficiency. <strong>Treatment:</strong> Central Acetylcholinesterase inhibitors (Donepezil, Rivastigmine, Galantamine) and NMDA antagonist (Memantine).</p>
                        </div>
                    </section>
                    <!-- END: Chapter 15 -->

                    <aside class="key-points-section" role="region" aria-labelledby="key-points-title">
                        <div class="key-points-wrapper">
                            <div class="key-points-header">
                                <span class="key-points-icon">‚≠ê</span>
                                <h3 id="key-points-title" class="key-points-title">Section II Key Points</h3>
                            </div>
                            <ul class="key-points-list">
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Benzodiazepines</strong> facilitate GABA action by increasing frequency of channel opening; <strong>Barbiturates</strong> increase duration.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Phenytoin</strong> and <strong>Carbamazepine</strong> block voltage-gated Na+ channels; <strong>Valproate</strong> has multiple mechanisms.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Morphine</strong> causes triad of coma, respiratory depression, and pin-point pupils in overdose.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Aspirin</strong> irreversibly inhibits COX; <strong>Paracetamol</strong> lacks significant anti-inflammatory action.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Clozapine</strong> is effective in resistant schizophrenia but causes agranulocytosis.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Levodopa</strong> is combined with <strong>Carbidopa</strong> to reduce peripheral side effects and enhance central efficacy.</p>
                                </li>
                            </ul>
                        </div>
                    </aside>

                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="section-01.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Section I: General Pharma</div>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>2</span>
                                <span class="progress-separator">/</span>
                                <span>16</span>
                            </div>
                        <a href="../index.html" class="nav-button nav-button--large">
                            <div class="nav-label">Go to</div>
                            <div class="nav-title">Index</div>
                        </a>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 12.5%;"></div>
                            </div>
                            <div class="progress-label">Section 2 of 16</div>
                        </div>
                        
                        <a href="section-03.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Section III: Local Anaesthetics</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>